Molecular interventions · 2004
Serotonin transporter: gene, genetic disorders, and pharmacogenetics.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Murphy Dennis L, Lerner Alicja, Rudnick Gary, Lesch Klaus-Peter
Аннотация
The highly evolutionarily conserved serotonin transporter (SERT) regulates the entire serotoninergic system and its receptors via modulation of extracellular fluid serotonin concentrations. Differences in SERT expression and function produced by three SERT genes and their variants show associations with multiple human disorders. Screens of DNA from patients with autism, ADHD, bipolar disorder, and Tourette's syndrome have detected signals in the chromosome 17q region where SERT is located. Parallel investigations of SERT knockout mice have uncovered multiple phenotypes that identify SERT as a candidate gene for additional human disorders ranging from irritable bowel syndrome to obesity. Replicated studies have demonstrated that the SERT 5'-flanking region polymorphism SS genotype is associated with poorer therapeutic responses and more frequent serious side effects during treatment with antidepressant SERT antagonists, namely, the serotonin reuptake inhibitors (SRIs).
Предметные рубрики MeSH
Amino Acid SequenceAnimalsBrainEvolution, MolecularGenetic Diseases, InbornGenetic Predisposition to DiseaseHumansMolecular Sequence DataNervous System DiseasesPharmacogeneticsPolymorphism, GeneticPositron-Emission TomographySequence AlignmentSequence Homology, Amino AcidSerotoninSerotonin Plasma Membrane Transport ProteinsSelective Serotonin Reuptake InhibitorsTomography, Emission-Computed, Single-Photon